Additional possible mechanisms of the action of ocrelizumab in multiple sclerosis on example of a case-report

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
O V BoykoA N Boyko

Abstract

Anti-B-cells products, including the anti-CD20 monoclonal antibody ocrelizumab, are widely coming to multiple sclerosis (MS) therapy. Its clinical-MRI efficacy in MS with relapses as well in primary progressive MS (PPMS) was proved by three phase III clinical studies. One example of the use of ocrelizumab use in aggressive MS showed the possibility of action on the leptomeningeal folliculi, seen at contract-enhancing MRI images.

References

Mar 1, 1995·Journal of Computer Assisted Tomography·P DemaerelA L Baert
Nov 20, 2012·The Journal of Clinical Investigation·H-Christian von BüdingenStephen L Hauser
Apr 25, 2014·Current Opinion in Neurology·Per Soelberg Sorensen
Jun 15, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Arumugam PalanichamyH-Christian von Büdingen
Apr 17, 2015·Multiple Sclerosis and Related Disorders·Jennifer GravesEmmanuelle Waubant
Nov 21, 2015·Multiple Sclerosis : Clinical and Laboratory Research·Ludwig KapposDavorka Tomic
Mar 13, 2016·Autoimmunity Reviews·Ron Milo
Nov 5, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Robert ZivadinovBianca Weinstock-Guttman
Dec 22, 2016·The New England Journal of Medicine·Stephen L HauserUNKNOWN OPERA I and OPERA II Clinical Investigators
Dec 22, 2016·The New England Journal of Medicine·Xavier MontalbanUNKNOWN ORATORIO Clinical Investigators
Apr 27, 2017·The New England Journal of Medicine·Xavier MontalbanJerry S Wolinsky
Apr 28, 2017·The New England Journal of Medicine·Florian DeisenhammerHarald Hegen
Jun 16, 2017·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·A N Boyko, E I Gusev
Sep 28, 2017·International Journal of Molecular Sciences·Klaus Lehmann-HornMartin S Weber
Oct 27, 2017·Acta Neurologica Scandinavica·P Sundström
May 3, 2018·Neuropsychiatric Disease and Treatment·Jessica FrauEleonora Cocco
May 19, 2018·Therapeutic Advances in Neurological Disorders·Patricia MuleroXavier Montalban

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Stephen L HauserLudwig Kappos
The New England Journal of Medicine
Christian Schoergenhofer, Bernd Jilma
The New England Journal of Medicine
Xavier MontalbanJerry S Wolinsky
The New England Journal of Medicine
Sorcha Mildiner, Stephen Malnick
The New England Journal of Medicine
Florian DeisenhammerHarald Hegen
© 2022 Meta ULC. All rights reserved